TILT Biotherapeutics Reports Publication on its Oncolytic Immunotherapy Platform in Pancreatic Cancer

Read full release

TILT Biotherapeutics Submits IND for Phase I Trial of Immunotherapeutic TILT-123 in Ovarian Cancer

Read full release

TILT Biotherapeutics, Docrates Cancer Center and Helsinki University Hospital open cancer immunotherapy clinical trial

Read full release

TILT Biotherapeutics advances cancer immunotherapy clinical trial achieving primary end point in the first cohort

Read full release

TILT Biotherapeutics secures over EUR 6 million to advance cancer immunotherapies into clinic

Read full release